This paper is in the following e-collection/theme issue:

Innovations and Technology in Cancer Care (352) Nursing in a Hospital Setting (84) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1157) Wearable Devices and Sensors (734) Mobile Health (mhealth) (2362) Mobile Apps for Cancer Care and Cancer Prevention and Screening (180)

Published on in Vol 8, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39271, first published .
Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Authors of this article:

Meghan B Skiba 1, 2 Author Orcid Image ;   Graham Harker 3 Author Orcid Image ;   Carolyn Guidarelli 4 Author Orcid Image ;   Mahmoud El-Gohary 5 Author Orcid Image ;   Fay Horak 3, 5 Author Orcid Image ;   Eric J Roeland 4, 6 Author Orcid Image ;   Rebecca Silbermann 4, 6 Author Orcid Image ;   Brandon Hayes-Lattin 4, 6 Author Orcid Image ;   Kerri Winters-Stone 4 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics

Journals

  1. Aryal S, Bachman S, Lyden K, Clay I. Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior. JCO Clinical Cancer Informatics 2023;(7) View